Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation.
The purpose of this study was to evaluate the influence of gamma-irradiation and dry heat sterilisation on the properties of a bioadhesive powder mixture containing ciprofloxacin and its corresponding ocular minitablets. The molecular weight characteristics of drum dried waxy maize starch (DDWM), employed as major component of the bioadhesive formulation, the decay kinetics of radicals, the rheological properties of the bioadhesive polymers and the microbial activity of ciprofloxacin were studied. The influence of the different sterilisation methods on the characteristics of the ocular minitablets was investigated by measuring the crushing strength, the friability, and the in vitro release of ciprofloxacin from the minitablets. Finally, the clinical value of the selected sterilised minitablets was evaluated in seven healthy volunteers. Both sterilisation methods similarly affected the properties of the bioadhesive formulation by inducing stable radicals and decreasing the molecular weight of DDWM, although no changes in the microbiological activity of ciprofloxacin were measured. An obvious influence of both sterilisation methods was observed in the in vitro release study. The crushing strength and friability of the minitablets were not significantly influenced by gamma-irradiation. Based on these data, gamma-irradiation was more adequate as sterilisation method for the bioadhesive ocular minitablets than dry heat sterilisation, because it affected the least the physical properties of the minitablets. Therefore, the gamma-sterilised minitablets were selected for an in vivo evaluation in seven volunteers. The concentration of ciprofloxacin in the tear film remained above its MIC value for the most common ocular pathogens for at least 8 h. Consequently, the gamma-irradiated minitablets containing ciprofloxacin can be considered as a promising formulation to treat bacterial keratitis and conjunctivitis.
Laboratory of Pharmaceutical Technology and Biopharmacy, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium.
W
W
Weyenberg
A
A
Vermeire
E
E
D'Haese
G
G
Vanhaelewyn
P
P
Kestelyn
F
F
Callens
H J
HJ
Nelis
J P
JP
Remon
A
A
Ludwig
D000269:Adhesives; D000328:Adult; D001419:Bacteria / Q000254:growth & development; D002850:Chromatography, Gel; D004578:Electron Spin Resonance Spectroscopy; D005079:Excipients; D005260:Female; D006801:Humans; D007202:Indicators and Reagents; D007700:Kinetics; D008297:Male; D008970:Molecular Weight; D011208:Powders / Q000737:chemistry*; D012212:Rheology; D013213:Starch; D013242:Sterilization; D013607:Tablets / Q000737:chemistry*; D014867:Water / Q000032:analysis
D000269:Adhesives; D005079:Excipients; D007202:Indicators and Reagents; D011208:Powders; D013607:Tablets; D014867:Water; D013213:Starch